Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoral Products Regulatory News (CRU)

Share Price Information for Coral Products (CRU)

Share Price is delayed by 15 minutes
Get Live Data
5.25    0.00 (0.00%)
Bid:
5.00
Ask:
5.50
Spread: 0.50 (10.00%)
Market Cap: £4.66m
CRU Live PriceLast checked at - London Stock Exchange

Intraday Coral Products Share Chart

Trading Statement

11 Jun 2024 07:00

RNS Number : 8773R
Coral Products PLC
11 June 2024
 

11 June 2024

Coral Products plc

(the "Group")

Post Close Trading Update and Re-instatement of Dividend

Coral Products plc, a group of specialist businesses in the design, UK manufacture and omni-channel supply of a wide range of bespoke plastic products based in Wythenshawe, Manchester, reports that revenue for the year to 30 April 2024 is expected to be over £31m (2023: £35.2m), underlying EBITDA for the Group is expected to be not less than £3.2m (2023: £3.9m), which is in line with recent market expectations.

It is our intention to reinstate an interim FY24 dividend of 0.25 pence to shareholders on the register at the close of business on 26 July 2024 and to be paid on 23 August 2024. In addition, a final dividend will be proposed, the level of which will be confirmed on completion of the audited results for the year.

CEO, Lance Burn, commented:

"We quickly recognised and communicated the adverse commercial impact experienced in our industry towards the end of 2023 and as a result, have been able to implement corrective commercial measures and organisational reform. We are pleased to say that we are beginning to see improvements in most of our markets, whilst being mindful of the continuing economic and geopolitical uncertainty.

We have created a focused and accountable new two-Division structure which is delivering performance and margin improvement through innovation, simplification and efficiency. We have exited low margin revenue streams in order to focus on profitability. Our recent investment of over £3m in new manufacturing capabilities is now fully commissioned serving new commercial channels and customers. This capital expenditure is expected to benefit the current financial year.

We also continue to strengthen our organisation to support our four strategic pillars of growth:

o Successfully managing complex commercial, product and service solutions.

o Excelling at UK manufacturing and technical innovation.

o Greater margin efficiency through investment in technology and people.

o Accessing commercial opportunity, scale and synergy through M&A.

I am pleased to see so much progress in such a brief time since I became CEO and I would like to thank my new colleagues for their support and effort as we accelerate a positive transformation of our business in pursuit of growth."

 

For further information, please contact: 

 

Coral Products plc

Lance Burn, CEO

 

 

Tel: 0161 946 9476

 

Nominated Adviser & Broker

Cavendish Capital Markets Limited

Adrian Hadden/Charlie Beeson (Corporate Finance)

Charlie Combe (ECM)

 

Tel: 020 7397 1966

 

Financial PR

Novella

Tim Robertson

Safia Colebrook

 

Tel: 020 3151 7008

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBBLLFZQLZBBE
Date   Source Headline
27th Aug 200910:51 amRNSInterim Management Statement
19th Aug 20092:45 pmRNSHolding(s) in Company
24th Jul 20099:22 amRNSAnnual Financial Report
6th Feb 200911:42 amRNSInterim Management Statement
9th Jan 200912:17 pmRNSHolding(s) in Company
9th Dec 200812:35 pmRNSReplacement - Half Yearly Report
5th Dec 20087:00 amRNSInterim Results
21st Nov 200811:30 amRNSAnnual Information Update
10th Sep 200812:06 pmRNSInterim Management Statement
31st Jul 200811:18 amRNSAnnual Report and Accounts
30th Apr 200810:06 amRNSInterim Management Statement
23rd Jan 200812:21 pmRNSDirector/PDMR Shareholding
7th Dec 200711:16 amRNSInterim Results
20th Nov 200710:47 amRNSAnnual Information Update
28th Sep 20072:37 pmRNSDirectorate Change
12th Sep 200712:36 pmRNSResult of EGM
28th Aug 20074:25 pmRNSFinal Results
24th Aug 200712:20 pmRNSNotice of EGM
24th Aug 200712:16 pmRNSCircular filed with FSA
14th Aug 200712:10 pmRNSDisposal
25th Jul 20076:23 pmRNSDirectorate Change
23rd Mar 20075:04 pmRNSTrading Statement
8th Dec 200612:10 pmRNSInterim Results
1st Dec 20062:35 pmRNSDirector/PDMR Shareholding
1st Dec 20062:30 pmRNSDirectorate Change
2nd Nov 20062:58 pmRNSDirector Disclosure
2nd Nov 200611:13 amRNSDirector/PDMR Shareholding
31st Oct 20065:29 pmRNSHolding(s) in Company
27th Oct 200610:20 amRNSDirectorate Change
5th Oct 200612:15 pmRNSHolding(s) in Company
29th Sep 20064:39 pmRNSHolding(s) in Company
29th Sep 20063:24 pmRNSAGM Statement
30th Aug 200610:58 amRNSAnnual Information Update
2nd Aug 20063:35 pmRNSChange of Adviser
7th Jul 20063:38 pmRNSFinal Results
20th Jun 20062:36 pmRNSDirectorate Change
9th Mar 200611:41 amRNSHolding in Company
3rd Mar 20062:20 pmRNSTrading Statement
22nd Feb 20064:38 pmRNSHolding in Company
3rd Feb 20064:41 pmRNSHoldings in Company
27th Jan 20061:02 pmRNSHolding(s) in Company
9th Dec 20057:00 amRNSInterim Results
12th Oct 20052:36 pmRNSAnnual Information Update
23rd Sep 200512:24 pmRNSResult of AGM
23rd Sep 200512:00 pmRNSAGM Statement
1st Sep 200512:16 pmRNSAnnual Report and Accounts
5th Jul 200512:50 pmRNSAdditional Listing
30th Jun 20054:46 pmRNSFinal Results
25th Feb 20054:28 pmRNSTrading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.